An Interactive Virtual Nephrologist to Engage Patients With Advanced CKD About Transplantation bit.ly/4z0Bjbg (OPEN ACCESS)
American Journal of Kidney Diseases
@ajkd.bsky.social
AJKD, official journal of @kidney.org, is the leading source of information devoted to clinical nephrology research and practice. AJKD.org | AJKDblog.org | Organizer of #NephMadness @nephmadness.bsky.social
Kidney Outcomes After Contrast Exposure in Patients Recovering From Dialysis-Requiring Acute Kidney Injury: A Target Trial Emulation Study bit.ly/4wsFue2
Racial and Ethnic Disparities in Living Donor Kidney Transplantation in California: 2010-2024 bit.ly/3QL7Uk6 (OPEN ACCESS)
Best in Class? The Comparative Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists in Preventing Incident CKD Stage 3 or Higher bit.ly/4cdFIxN (FREE)
Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in the Chinese Population and Its Implications for Clinical Practice bit.ly/43r4RQY
NEW on the #AJKDBlog: @maximalchange.bsky.social interviews Dana Rizk on B-Cell Modulators in IgA Nephropathy
B-Cell Modulators in IgA Nephropathy: An Interview
In IgA nephropathy (IgAN), elevated levels of the circulating autoantigen galactose-deficient IgA1 are critical to disease pathogenesis. Genetic as well as in vitro, in vivo, and human immunologic …
bit.ly
NEW on the #AJKDBlog: @maximalchange.bsky.social interviews Dana Rizk on B-Cell Modulators in IgA Nephropathy
B-Cell Modulators in IgA Nephropathy: An Interview
In IgA nephropathy (IgAN), elevated levels of the circulating autoantigen galactose-deficient IgA1 are critical to disease pathogenesis. Genetic as well as in vitro, in vivo, and human immunologic …
bit.ly
The August 2026 issue of AJKD is available now! Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
Highlights from the August 2026 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was…
bit.ly
EDITORIAL: Deceased Donor Kidney Allocation Changes and Pediatric Recipients: Are We Making the Best Match? bit.ly/4wqLi8h (FREE)
#KDOQI US Commentary on the @KDIGO.org 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) bit.ly/KDOQI26IgAN (FREE) @isabelleayoub.bsky.social @maximalchange.bsky.social @nkf-professionals.bsky.social
⚡️AJKD Express is an expedited consideration process for full-length original research articles: Authors of eligible #AJKDExpress articles will be notified of decision within 7-16 business days.⚡️ Details on #AJKDBlog: bit.ly/2Ws8rtp
Journal Announcement: AJKD Express
Recognizing the efficiency losses to authors and reviewers when manuscripts turned down by a journal with a top-class review process are submitted to a new journal, AJKD offers an expedited conside…
bit.ly
This Special Collection features the top cited Original Investigations published in 2023 and 2024 that contributed to AJKD’s 2025 Impact Factor of 9.4: bit.ly/AJKDTopCited (FREE)
NEW on the #AJKDBlog: @maximalchange.bsky.social interviews Dana Rizk on B-Cell Modulators in IgA Nephropathy
B-Cell Modulators in IgA Nephropathy: An Interview
In IgA nephropathy (IgAN), elevated levels of the circulating autoantigen galactose-deficient IgA1 are critical to disease pathogenesis. Genetic as well as in vitro, in vivo, and human immunologic …
bit.ly
#KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis bit.ly/4g3r1Qc (FREE)
NKF's new KDOQI U.S. Commentary offers practical recommendations to help improve care for people living with lupus nephritis. www.kidney.org/press-room/n...
National Kidney Foundation Highlights New Guidance Reflecting Rapid Advances in Lupus Nephritis Care
Tune in for the latest research and perspectives on kidney health from NKF.
kidney.org
NEW on the #AJKDBlog: @maximalchange.bsky.social interviews Dana Rizk on B-Cell Modulators in IgA Nephropathy bit.ly/4vT7uqn
B-Cell Modulators in IgA Nephropathy: An Interview
In IgA nephropathy (IgAN), elevated levels of the circulating autoantigen galactose-deficient IgA1 are critical to disease pathogenesis. Genetic as well as in vitro, in vivo, and human immunologic …
bit.ly
Podocyte-Targeted Therapy in Focal Segmental Glomerulosclerosis: Insights from a Phase 2 Trial of TRPC6 Inhibition bit.ly/4vCoi5j (FREE)
Urinary CXCL9 and CXCL10, Interstitial Inflammation and Disease Activity Over Time in Acute Interstitial Nephritis bit.ly/3RF3s6X (OPEN ACCESS)
This Special Collection features the top cited Original Investigations published in 2023 and 2024 that contributed to AJKD’s 2025 Impact Factor of 9.4: bit.ly/AJKDTopCited (FREE)
Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)–Induced Hypophosphatemia bit.ly/4yLHsIr @grahamabra.bsky.social @bhallaresearch.bsky.social @mcaccia.bsky.social
Where does brain injury begin in kidney disease? Is it driven by CKD itself or by the physiologic stress of dialysis? Tune in as our faculty break down the evidence and debate the impact. 🎧 bit.ly/3DamjQ9 (Episode 052) #Nephrology #NephMadness #ClinicalEducation
Kidney Commute
NKF Mega Menu
bit.ly
CALL FOR SUBMISSIONS: How has #kidneydisease impacted your life? Consider sharing your experience to our "In A Few Words" feature. We welcome submissions from patients/health professionals/family members. Details on the #AJKDBlog:
Call for Submissions: In A Few Words
“A doctor, like a writer, must have a voice of his own, something that conveys the timbre, the rhythm, the diction, and the music of his humanity, that compensates us for all the speechless machine…
bit.ly
NEW Blog Commentary from AJKD Editorial Intern @kashvilunawat.bsky.social on the #AJKDBlog: Why Physical Function Matters More Than We Think in CKD bit.ly/3Tf29MG (FREE)
Kidney Transplantation Post–Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma bit.ly/4x9z3wY (OPEN ACCESS)
